Pre-treatment of primary CLL cells with 17-DMAG significantly inhibited the migration towards both SDF-1 (p = 0.006) and CXCL13 (p < 0.001) (Figure 4A). Here, CXCL12 is linked to B-cell chronic lymphocytic leukemia.